| Dr Kent Handfield, MD | |
|
609 S Main St, Wolfeboro, NH 03894-4419 | |
| (603) 569-3376 | |
| Not Available |
| Full Name | Dr Kent Handfield |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 19 Years |
| Location | 609 S Main St, Wolfeboro, New Hampshire |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780798140 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 21025 (New Hampshire) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Huggins Hospital | Wolfeboro, NH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Adult And Pediatric Dermatology Pc | 7012988306 | 31 |
News Archive
Tenet Healthcare Corporation and Aetna announced today that they have signed a new multi-year agreement.
Panasonic Corporation of North America has announced it will launch On4TodayTM, a tablet-based telehealth service, in November. T
The discovery of a potential new anti-malarial drug by a UT Southwestern Medical Center-led research team has been awarded Project of the Year by Medicines for Malaria Venture.
AmerisourceBergen Corporation today announced that it has completed the previously announced acquisition of World Courier Group, Inc., a privately held leading global specialty transportation and logistics provider for the biopharmaceutical industry.
A drug that suppresses the immune system and reduces inflammation has been shown to be effective in treating lung disease associated with the devastating connective tissue disease scleroderma, according to results presented at the American Thoracic Society International Conference on May 23.
› Verified 8 days ago
| Entity Name | Adult & Pediatric Dermatology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285614834 PECOS PAC ID: 7012988306 Enrollment ID: O20101111001171 |
News Archive
Tenet Healthcare Corporation and Aetna announced today that they have signed a new multi-year agreement.
Panasonic Corporation of North America has announced it will launch On4TodayTM, a tablet-based telehealth service, in November. T
The discovery of a potential new anti-malarial drug by a UT Southwestern Medical Center-led research team has been awarded Project of the Year by Medicines for Malaria Venture.
AmerisourceBergen Corporation today announced that it has completed the previously announced acquisition of World Courier Group, Inc., a privately held leading global specialty transportation and logistics provider for the biopharmaceutical industry.
A drug that suppresses the immune system and reduces inflammation has been shown to be effective in treating lung disease associated with the devastating connective tissue disease scleroderma, according to results presented at the American Thoracic Society International Conference on May 23.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kent Handfield, MD 526 Main St Ste 302, Acton, MA 01720-3301 Ph: (978) 371-7010 | Dr Kent Handfield, MD 609 S Main St, Wolfeboro, NH 03894-4419 Ph: (603) 569-3376 |
News Archive
Tenet Healthcare Corporation and Aetna announced today that they have signed a new multi-year agreement.
Panasonic Corporation of North America has announced it will launch On4TodayTM, a tablet-based telehealth service, in November. T
The discovery of a potential new anti-malarial drug by a UT Southwestern Medical Center-led research team has been awarded Project of the Year by Medicines for Malaria Venture.
AmerisourceBergen Corporation today announced that it has completed the previously announced acquisition of World Courier Group, Inc., a privately held leading global specialty transportation and logistics provider for the biopharmaceutical industry.
A drug that suppresses the immune system and reduces inflammation has been shown to be effective in treating lung disease associated with the devastating connective tissue disease scleroderma, according to results presented at the American Thoracic Society International Conference on May 23.
› Verified 8 days ago